Rifat Hasina

1.8k total citations
38 papers, 1.1k citations indexed

About

Rifat Hasina is a scholar working on Molecular Biology, Cancer Research and Otorhinolaryngology. According to data from OpenAlex, Rifat Hasina has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Otorhinolaryngology. Recurrent topics in Rifat Hasina's work include Head and Neck Cancer Studies (9 papers), Cancer Genomics and Diagnostics (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Rifat Hasina is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Cancer Genomics and Diagnostics (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Rifat Hasina collaborates with scholars based in United States, Taiwan and Japan. Rifat Hasina's co-authors include Mark W. Lingen, Ravi Salgia, Martin Sattler, Patrick A. Singleton, M. J. Moss, Nishant Agrawal, Tamara Mirzapoiazova, Tara C. Gangadhar, Mamatha M. Reddy and Everett E. Vokes and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Rifat Hasina

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Rifat Hasina

Since Specialization

Citations

This map shows the geographic impact of Rifat Hasina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rifat Hasina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rifat Hasina more than expected).

Fields of papers citing papers by Rifat Hasina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rifat Hasina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rifat Hasina. The network helps show where Rifat Hasina may publish in the future.

Co-authorship network of co-authors of Rifat Hasina

This figure shows the co-authorship network connecting the top 25 collaborators of Rifat Hasina. A scholar is included among the top collaborators of Rifat Hasina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rifat Hasina. Rifat Hasina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV. 2024 ·Journal of Clinical Oncology ·Ari J. Rosenberg, Aditya Juloori, Evgeny Izumchenko, John Cursio, Zhen Gooi, Elizabeth A. Blair, Mark W. Lingen, Nicole A. Cipriani, Rifat Hasina, (unknown), F. R. Jones, Christopher Plescia, (unknown), (unknown), (unknown), Daniel J. Haraf, Alexander T. Pearson, Everett E. Vokes, Nishant Agrawal	4
2	886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment 2023 ·Annals of Oncology ·Ari J. Rosenberg, Evgeny Izumchenko, Aditya Juloori, Zhen Gooi, Alexander T. Pearson, Ann M. Vannier, Elizabeth A. Blair, (unknown), (unknown), Mark W. Lingen, Nicole A. Cipriani, Rifat Hasina, (unknown), Daniel J. Haraf, Everett E. Vokes, Nishant Agrawal	0
3	Abstract 4897: PRT543, a methyl transferase inhibitor, has potent anti-tumor activity against adenoid cystic carcinoma of salivary glands 2023 ·Cancer Research ·(unknown), Alka Singh, Xiangying Chen, (unknown), Claudia Wing, (unknown), (unknown), (unknown), (unknown), (unknown), Peggy Scherle, Mark W. Lingen, Rifat Hasina, Alexander T. Pearson, Ari J. Rosenberg, (unknown), (unknown), Nishant Agrawal, Evgeny Izumchenko	1
4	Evaluation of Cell-Free HPV DNA in Patients With HPV-Associated Oropharyngeal Cancer Treated With Induction Chemotherapy and Response-Adaptive Therapy 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Ari J. Rosenberg, (unknown), Rifat Hasina, (unknown), (unknown), Johannes Fredebohm, (unknown), Evgeny Izumchenko, Neha Agrawal	0
5	Tumor DNA: an emerging biomarker in head and neck cancer 2017 ·Cancer and Metastasis Reviews ·Joseph A. Bellairs, Rifat Hasina, Nishant Agrawal	39
6	Increased μ-opioid receptor expression in metastatic lung cancer 2014 ·British Journal of Anaesthesia ·Patrick A. Singleton, Tamara Mirzapoiazova, Rifat Hasina, Ravi Salgia, M. J. Moss	106
7	MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma 2014 ·PLoS ONE ·Rajani Kanteti, (unknown), Ichiro Kawada, Frances E. Lennon, (unknown), Raphael Bueno, Rifat Hasina, Aliya N. Husain, Wickii T. Vigneswaran, Tanguy Y. Seiwert, Hedy L. Kindler, Ravi Salgia	47
8	Dramatic Antitumor Effects of the Dual MET/RON Small-Molecule Inhibitor LY2801653 in Non–Small Cell Lung Cancer 2013 ·Cancer Research ·Ichiro Kawada, Rifat Hasina, (unknown), Jeffrey Mueller, (unknown), Aliya N. Husain, Everett E. Vokes, Ravi Salgia	52
9	The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target 2013 ·PLoS ONE ·(unknown), Ren Liu, Cleo E. Rolle, Yi‐Hung Carol Tan, Valery Krasnoperov, Rajani Kanteti, Maria Tretiakova, Gustavo M. Cervantes, Rifat Hasina, (unknown), A. John Iafrate, Theodore Karrison, Mark K. Ferguson, Aliya N. Husain, Leonardo Faoro, Everett E. Vokes, Parkash S. Gill, Ravi Salgia	56
10	Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research 2011 ·Journal of Visualized Experiments ·(unknown), Matthew R. Robinson, Suvobroto Nandi, Leonardo Faoro, (unknown), Rajani Kanteti, (unknown), Tara C. Gangadhar, Thomas A. Hensing, Rifat Hasina, Aliya N. Husain, Mark K. Ferguson, Theodore Karrison, Ravi Salgia	4
11	Abstract 1625: Role of EphB4 in esophageal cancer: Expression, amplification, and therapeutic inhibition 2011 ·Cancer Research ·Rifat Hasina, (unknown), Soheil Yala, Nathan M. Mollberg, (unknown), (unknown), Rajani Kanteti, Aliya N. Husain, Mitchell C. Posner, (unknown), Wickii T. Vigneswaran, Mark K. Ferguson, Victoria Villaflor, (unknown), Parkash S. Gill, Ravi Salgia	2
12	ZD6474 is an Effective Chemopreventive Agent in the Mouse 4-NQO Model of Oral Carcinogenesis 2010 ·Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ·(unknown), Guolin Zhou, Rifat Hasina, Lee Martin, Kristen Kasza	1
13	CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases 2010 ·PLoS ONE ·Yi‐Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi, Rajani Kanteti, (unknown), Kenan Onel, Rifat Hasina, (unknown), Essam El‐Hashani, Gustavo M. Cervantes, Matthew R. Robinson, Stephen C. Kales, Stanley Lipkowitz, Theodore Karrison, Martin Sattler, Everett E. Vokes, Yi‐Ching Wang, Ravi Salgia	84
14	MET Mutations And Function In Lung Cancer 2010 ·Journal of Thoracic Oncology ·Ravi Salgia, (unknown), Kenzo Soejima, (unknown), Essam El‐Hashani, Rajani Kanteti, Sumon Nandi, (unknown), Rifat Hasina, Ichiro Kawada	1
15	Network Modeling Identifies Molecular Functions Targeted by miR-204 to Suppress Head and Neck Tumor Metastasis 2010 ·PLoS Computational Biology ·Younghee Lee, Xinan Yang, Yong Huang, Hanli Fan, Qingbei Zhang, (unknown), Jianrong Li, Rifat Hasina, Chao Cheng, Mark W. Lingen, Mark Gerstein, Ralph R. Weichselbaum, Hongyun Xing, Yves A. Lussier	129
16	Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications 2008 ·Laboratory Investigation ·Rifat Hasina, Mark Whipple, Leslie E. Martin, Winston Patrick Kuo, Lucila Ohno‐Machado, Mark W. Lingen	44
17	NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype 2005 ·Oncogene ·Rifat Hasina, (unknown), (unknown), Lee Martin, Xiaole Qi, Christophe Brigaudeau, Rocky Pramanik, (unknown), Lionel Coignet, Mark W. Lingen	28
18	Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma 2002 ·International Journal of Cancer ·(unknown), (unknown), Rifat Hasina, Mark W. Lingen	24
19	Gene expression levels in different stages of progression in oral squamous cell carcinoma. 2002 ·PubMed ·Winston Patrick Kuo, Tor‐Kristian Jenssen, Peter J. Park, Mark W. Lingen, Rifat Hasina, Lucila Ohno‐Machado	14
20	Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line 1999 ·British Journal of Cancer ·Rifat Hasina, Kunio Matsumoto, (unknown), (unknown), M Sakuda, Takashi Nakamura	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact